Skip to main content
OpenTrials
Completed

NCT Number: NCT00698282

Single and Multiple Ascending Doses of AZD1981 in Japan

The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

20 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Research Site

Berkshire, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy Japanese and Caucasian males

Exclusion criteria

  • Other clinically relevant disease or disorders

Treatment and study plan

AZD1981

Drug

Oral tablet, 250 mg single dose

Placebo

Drug

Primary outcomes

  1. Adverse events

    Time frame: All the time

  2. Plasma drug concentration

    Time frame: Every hour

Secondary outcomes

  1. Clinical chemistry

    Time frame: day 1 and 9

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Randomised, Placebo-Controlled, Double-Blind, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Doses of AZD1981 in Healthy Male Japanese and Caucasian Subjects

Acronym: JSAD/JMAD

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Jun 17, 2008
Registry last updated
Dec 1, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.